Business Description
Biomind Labs Inc
NAICS : 541714
SIC : 3741
Compare
Compare
Traded in other countries / regions
BMND.Canada3XI.GermanyBMNDF.USA IPO Date
2021-07-28Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -8.16 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.24 | |||||
| 9-Day RSI | 41.96 | |||||
| 14-Day RSI | 44.52 | |||||
| 6-1 Month Momentum % | -23.33 | |||||
| 12-1 Month Momentum % | -37.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -693.79 | |||||
| ROA % | -381.87 | |||||
| ROIC % | -1966.63 | |||||
| ROC (Joel Greenblatt) % | -4193.47 | |||||
| ROCE % | -692.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -8.72 | |||||
| EV-to-EBITDA | -8.85 | |||||
| EV-to-FCF | -13.92 | |||||
| Earnings Yield (Greenblatt) % | -11.47 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Biomind Labs Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.048 | ||
| Beta | 0 | ||
| Volatility % | 87.93 | ||
| 14-Day RSI | 44.52 | ||
| 14-Day ATR (C$) | 0.073824 | ||
| 20-Day SMA (C$) | 0.59875 | ||
| 12-1 Month Momentum % | -37.27 | ||
| 52-Week Range (C$) | 0.16 - 1.4 | ||
| Shares Outstanding (Mil) | 74.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomind Labs Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomind Labs Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomind Labs Inc Frequently Asked Questions
What is Biomind Labs Inc(NEOE:BMND)'s stock price today?
The current price of NEOE:BMND is C$0.42. The 52 week high of NEOE:BMND is C$1.40 and 52 week low is C$0.16.
When is next earnings date of Biomind Labs Inc(NEOE:BMND)?
The next earnings date of Biomind Labs Inc(NEOE:BMND) is .
Does Biomind Labs Inc(NEOE:BMND) pay dividends? If so, how much?
Biomind Labs Inc(NEOE:BMND) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
